	Metabolic reprogramming-associated genomic instability drives colorectal cancer progression via the UBXN1-NF-ÎºB axis. Am J Transl Res Qian L, Li Z, Yang T, Xia S, Jin L, Zhu C, Jing W, Wang Y, Ye Y, Shen Y, Li L, Peng H, Yu Q. PMID: 42007143 [PubMed - as supplied by publisher]
	Personalised therapy in pancreatic carcinoma - a forthcoming opportunity? Prz Gastroenterol P, Durlik M. PMID: 42005944 [PubMed]
	The effect of gastrojejunostomy on carbohydrate metabolism in patients with pancreatic cancer. Prz Gastroenterol Grz, Majos A, Durczy, Hogendorf P, Hejduk N, Strzelczyk J. PMID: 42005943 [PubMed]
	Breaking Through the Barrier: Nanoparticle-Driven MRI Strategies for Diagnosis and Therapy of Pancreatic Cancer. ACS Nanosci Au Amaolo A, Scarciglia A, Sorrentino M, Di Gregorio E, Ferrauto G. PMID: 42004273 [PubMed]
	Molecular Probes for Pancreatic Cancer Diagnosis: Recent Advances and Further Perspectives. Small Li J, He W, Dai L, Fan H, Yu X. PMID: 42003523 [PubMed - as supplied by publisher]
	The association between prostate cancer and sexual function: an observational cohort study. J Sex Med Yao M, Dilixiati D, Waili A, Fan Y, Mei J, Ailiyaer A, Tuerxunmaimaiti A, Tao N, Dilixiati R, Li XD, An H. PMID: 42003309 [PubMed - in process]
	Clinical Characteristics and Cancer-Specific Survival of Adolescents and Young Adults With Pancreatic Neuroendocrine Tumors: A SEER-Based Study. Cancer Control Huang L, Gao F, Chen J, Xu X, Liu L. PMID: 42002890 [PubMed - indexed for MEDLINE]
	ATP Binding Cassette Subfamily D Member 1: A Highly Sensitive Diagnostic Marker for Solid Pseudopapillary Neoplasm of Pancreas in Biopsy Samples--A Multi-Institutional Study. Hum Pathol Liu Y, Peng J, He R, Xue X, Cui J, Li M, Liu YA, Xu W, Gao X, Wang Y, Zhang Z, Lu H, Song Z, Hu P, Zhao Y, Wang W. PMID: 42002112 [PubMed - as supplied by publisher]
	Prognostic nutritional index and cancer prognostic outcomes: an umbrella review of systematic reviews and meta-analyses of observational studies. Adv Nutr Li ZT, Sun ML, Liu FH, Li Y, Bao RH, Jiang XF, Liu J, Lu Z, Yang Y, Yu Y, Zhao N, Chen Q, Fang Q, Feng ZF, Jia XX, Li DR, Luan M, Ma J, Wang Y, Xu YL, Yang D, Yang M, Yang R, Bai XL, Yang J, Li TG, Gong TT, Wu QJ. PMID: 42001952 [PubMed - as supplied by publisher]
	Investigation of molecular immune regulation mechanisms and therapeutic target prediction in pancreatic cancer based on bioinformatics and genetics. Clinics (Sao Paulo) Dong C, Guan J, Dong L, Yu Y, Zhang X, Li Z, Zhang X, Mo C. PMID: 42001564 [PubMed - as supplied by publisher]
	Characterization of the Oral Bacteria in Patients With Neuroendocrine Tumors of the Pancreas. Cancer Med Yao J, Fei C, Wu H, Zhang Z, Jiang Z. PMID: 42001450 [PubMed - indexed for MEDLINE]
	Clear cell renal cell carcinoma metastatic to the pancreas and gastrointestinal tract: a clinicopathologic study of 32 cases. Ann Diagn Pathol Wang L, Aktas BK, Yilmaz O, Kopach P. PMID: 42000700 [PubMed - as supplied by publisher]
	Explainable Lightweight Model Using Low-Rank and Convolutional Block Attention for Pancreatic Cancer Diagnosis. Int J Med Robot Tanwar V, Sharma B, Yadav DP, Liatsis P. PMID: 41999341 [PubMed - indexed for MEDLINE]
	Timing of Adjuvant S-1 Chemotherapy and Survival After Pancreatectomy for Pancreatic Cancer: An Ancillary Analysis of the JASPAC 01 Trial. J Hepatobiliary Pancreat Sci Lee D, Okamura Y, Nanno Y, Mizumoto T, Ishida J, Gotohda N, Toyama H, Fukutomi A, Boku N, Uesaka K. PMID: 41999030 [PubMed - as supplied by publisher]
	Clinicopathological Features and Prognostic Factors of Gastroenteropancreatic Neuroendocrine Tumors: A Single-Center Experience. Cancer Control Ergenç M, Yaz, Y, Akmercan A, Bulut A, Karpuz , Co, Bozkurtlar E, Uprak TK, At, U, Cingi A, Günal Ö, Ye. PMID: 41998800 [PubMed - indexed for MEDLINE]
	Neoadjuvant or conversion therapy nullifies the prognostic impact of surgical margin width in hepatocellular carcinoma: a single-center retrospective study. BMC Surg Xie H, Liao Y, Liang T, Huang H, Wei Y, Yang K, Qin C, Chen M, Song J, Zhou X, Zhou Y, Yang C, Liao X, Su H, Zhu G, Peng M, Han C, Peng's T. PMID: 41998639 [PubMed - as supplied by publisher]
	Author Correction: PanMETAI - a high performance tabular foundation model for accurate pancreatic cancer diagnosis via NMR metabolomics. Nat Commun Wu DN, Jen J, Fajiculay E, Hsu MF, Chang MC, Yeh JC, Sargsyan K, Kupcinskas J, Skieceviciene J, Steponaitiene R, Morkunas E, Gedgaudiene G, Hsu CP, Chang YT, Hu CM. PMID: 41997919 [PubMed - in process]
	A community-hospital collaborative diagnostic pathway for earlier detection of pancreatic cancer: Long-term impact of the Onomichi Method. Pancreatology Hanada K, Shimizu A, Tanaka S, Sasaki N. PMID: 41997755 [PubMed - as supplied by publisher]
	The impact of MRI on real-world staging pathways and management timelines in pancreatic cancer: A systematic review. Eur J Surg Oncol Memon M, Chatzielefthreiou E, Kowal MR, Shapey I, Albazaz R, Smith A, Pathak S. PMID: 41996777 [PubMed - as supplied by publisher]
	Global, regional, and national analyses of the burden of pancreatic cancer attributable to high fasting plasma glucose from 1990 to 2021: A longitudinal observational study. Medicine (Baltimore) Han J, Liang Q, Lv Y, Chen H, Lei X, Liao C, Yang S, Chu F. PMID: 41995512 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 59763

Page 1 of 2989



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy